CG Oncology, Inc. Common stockCGONNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, strong compound growth.
Left:
||||
Enterprise value to sales ratio
Latest
1348.18
↓ 79% below average
Average (3y)
6569.88
Historical baseline
Range
High:12589.90
Low:235.41
CAGR
+78.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 1348.18 | -88.9% |
| 2023 | 12106.05 | -3.8% |
| 2022 | 12589.90 | +5248.0% |
| 2021 | 235.41 | - |